Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
ANZ Journal of Surgery|August 24, 2021
Real world outcomes of neoadjuvant chemotherapy and radiotherapy for borderline resectable pancreatic cancer: a multicentre observational studyAndrew Ohyama Parsonson, Elizabeth Connolly, Mark Lee, et al.European Journal of Clinical Investigation|April 8, 2025
Total lesion glycolysis is a promising predictor of chemo-response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgerySooin Byeon, Bridget Abbott, Paul Roach, et al.Journal of Medical Imaging and Radiation Oncology|May 25, 2026
Use of Interventional Radiologically Guided Covered Self-Expanding Metallic Stents for the Treatment of Hepaticojejunostomy LeaksCaroline Yang, Hiro Masuda, Neel Gore, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2020
Tissue biomarker panel as a surrogate marker for squamous subtype of pancreatic cancerSumit Sahni, Elizabeth A Moon, Viive M Howell, et al.Journal of Clinical Medicine|July 2, 2021
Optimal Upfront Treatment in Surgically Resectable Pancreatic Cancer Candidates: A High-Volume Center Retrospective AnalysisSarah Maloney, Malinda Itchins, Jennifer Arena, et al.Cancer Medicine|August 3, 2023
Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapySumit Sahni, Christopher Nahm, Mahsa S Ahadi, et al.Journal of Medical Imaging and Radiation Oncology|June 16, 2025
SPAN-C: Results of a Phase II Clinical Trial of Stereotactic Body Radiotherapy in Pancreatic Ductal AdenocarcinomaJoseph Chan, Andrew Kneebone, Gabrielle Metz, et al.ANZ Journal of Surgery|February 19, 2021
Gallbladder carcinoma outcomes in an Australian tertiary referral hospitalMarianne F T Wietsma, Charles Molloy, Nazim Bhimani, et al.Journal of Clinical Medicine|March 11, 2023
The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic CancerSarah Maloney, Nick Pavlakis, Malinda Itchins, et al.The American Journal of Surgical Pathology|October 19, 2020
A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel ApproachAngela Chou, Mahsa Ahadi, Jennifer Arena, et al.Pageof 6